Action Biote - BTMD

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

6,20

Prix Achat

5,85

Prix Vente

8,21

Volume échangé

113 754

6,00 Fourchette du Jour 6,30

3,6538 Plage de 52 semaines 8,44

Cap du marché

336,89M

Clôture Veille

6,03

Ouverture

6,00

Dernière Transaction

6.51

Dernière heure de transaction

Volume financier

US$ 701 743

VWAP

6,169

Volume moyen (3 m)

145 343

Actions en circulation

54 337 138

Rendement du Dividende

Ratio Cours sur Bénéfices

101,31

Bénéfice par action (BPA)

0,06

Chiffre d'affairess

185,36M

Bénéfice net

3,32M

Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business. Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business.

Secteur

Medicinal Chems,botanicl Pds

Industrie

Medicinal Chems,botanicl Pds

Site Web

www.biote.com

Siège social

Wilmington, Delaware, USA

Fondé

Biote Corporation est coté dans le secteur Medicinal Chems,botanicl Pds de la NASDAQ avec le ticker BTMD. Le dernier cours de clôture d'Biote était de US$6,03. Au cours de la dernière année, les actions de Biote ont été négociées dans une fourchette de prix de US$ 3,6538 à US$ 8,44.

Biote compte actuellement 54 337 138 actions en circulation. La capitalisation boursière d'Biote est de US$327,65 million. Biote a un ratio cours/bénéfice (ratio PE) de 101.31.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Biote Reports Third Quarter 2024 Financial Results

Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages Biote...

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports Second Quarter 2024 Financial Results

Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance Biote (NASDAQ: BTMD), a leading solutions...

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness...

Biote Reports First Quarter 2024 Financial Results

Procedure revenue growth and strengthened profitability drive solid financial performance Phased launch of BioteRx remains on track Reaffirms 2024 financial guidance, with an acceleration in...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.01	-0.161030595813	6.21	6.36	5.7582	93143	6.07097617	CS
4	-0.26	-4.02476780186	6.46	6.9	5.68	123030	6.2535923	CS
12	1.04	20.1550387597	5.16	6.98	5.005	145343	6.01126539	CS
26	-1.45	-18.954248366	7.65	8.44	4.935	171345	6.32744284	CS
52	1.5	31.914893617	4.7	8.44	3.6538	162685	6.19864287	CS
156	-3.84	-38.2470119522	10.04	10.51	2.75	123969	5.71835481	CS
260	-3.84	-38.2470119522	10.04	10.51	2.75	123969	5.71835481	CS

BTMD - Frequently Asked Questions (FAQ)

What is the current Biote share price?

The current share price of Biote is US$ 6,20

How many Biote shares are in issue?

Biote has 54 337 138 shares in issue

What is the market cap of Biote?

The market capitalisation of Biote is USD 327,65M

What is the 1 year trading range for Biote share price?

Biote has traded in the range of US$ 3,6538 to US$ 8,44 during the past year

What is the PE ratio of Biote?

The price to earnings ratio of Biote is 101,31

What is the cash to sales ratio of Biote?

The cash to sales ratio of Biote is 1,81

What is the reporting currency for Biote?

Biote reports financial results in USD

What is the latest annual turnover for Biote?

The latest annual turnover of Biote is USD 185,36M

What is the latest annual profit for Biote?

The latest annual profit of Biote is USD 3,32M

What is the registered address of Biote?

The registered address for Biote is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Biote website address?

The website address for Biote is www.biote.com

Which industry sector does Biote operate in?

Biote operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
FCUVFocus Universal Inc	US$ 0,9499 (174,93%)	259,78M
NITON2OFF Inc	US$ 2,6306 (145,85%)	350,92M
CRNCCerence Inc	US$ 19,33 (143,76%)	159,55M
KITTNauticus Robotics Inc	US$ 3,8249 (140,56%)	104,78M
ACONAclarion Inc	US$ 0,2984 (110,14%)	305,59M
HWHHWH International Inc	US$ 0,4621 (-28,80%)	7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5,69 (-26,30%)	24,77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5,59 (-23,42%)	161,15k
PTLEPTL Ltd	US$ 9,35 (-23,30%)	1,04M
NXUNXU Inc	US$ 0,725868 (-22,78%)	7,59M
NITON2OFF Inc	US$ 2,6306 (145,85%)	358,28M
TGLTreasure Global Inc	US$ 0,382 (101,58%)	337,5M
ACONAclarion Inc	US$ 0,2984 (110,14%)	305,64M
FCUVFocus Universal Inc	US$ 0,9499 (174,93%)	260,93M
NVDANVIDIA Corporation	US$ 144,47 (4,45%)	230,01M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Biote Corporation (BTMD) Cours

Biote Corporation (BTMD)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Biote Corporation

BTMD Dernières nouvelles

BTMD - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application